CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2018	Sep. 30, 2017
Reconciliation of net income to cash provided by operating activities:
Net income	$ 44,163	$ 42,076
Add (deduct):
Depreciation and amortization	18,609	19,397
Provision for bad debt	510	697
Investment and other (gains) losses – net	(4,345)	1,436
Amortization of net premium on investments available-for-sale	4,617	5,114
Payments for title losses (in excess of) lesser than provisions	(1,106)	6,697
Adjustment for insurance recoveries of title losses	1,023	757
Decrease (increase) in receivables – net	2,020	(13,032)
Increase in other assets – net	(406)	(5,633)
Decrease in payables and accrued liabilities – net	(23,480)	(20,482)
Change in net deferred income taxes	(1,693)	8,749
Net income from equity investees	(1,344)	(1,813)
Dividends received from equity investees	2,187	2,053
Stock-based compensation expense	3,039	2,078
Other – net	(61)	(46)
Cash provided by operating activities	43,733	48,048
Investing activities:
Proceeds from sales of investments in securities	32,500	55,533
Proceeds from matured investments in debt securities	25,258	33,867
Purchases of investments in securities	(35,683)	(125,415)
Net purchases of short-term investments	(366)	(327)
Purchases of property and equipment, and real estate – net	(8,478)	(12,411)
Cash paid for acquisition of businesses	(17,639)	(17,784)
Other – net	327	960
Cash used by investing activities	(4,081)	(65,577)
Financing activities:
Payments on notes payable	(16,767)	(18,848)
Proceeds from notes payable	9,583	48,043
Distributions to noncontrolling interests	(8,665)	(8,376)
Repurchases of common stock	(687)	0
Cash dividends paid	(21,195)	(21,100)
Payment of contingent consideration related to an acquisition	0	(1,298)
Purchase of remaining interest in consolidated subsidiary	(1,102)	(1,014)
Cash used by financing activities	(38,833)	(2,593)
Effects of changes in foreign currency exchange rates	(1,229)	3,096
Decrease in cash and cash equivalents	(410)	(17,026)
Cash and cash equivalents at beginning of period	150,079	185,772
Cash and cash equivalents at end of period	$ 149,669	$ 168,746